Aimco Pesticides Limited (BOM:524288)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	47.67	36.52	16.72	40.74	38.6
Trading Asset Securities	-	0.16	0.15	40.3	0.23
Cash & Short-Term Investments	47.67	36.68	16.87	81.05	38.83
Cash Growth	29.95%	117.43%	-79.18%	108.72%	-32.05%
Accounts Receivable	504.11	465.18	246.16	409.16	255.82
Other Receivables	-	17.21	16.98	0.11	0.23
Receivables	504.23	483	263.45	411.69	256.47
Inventory	728.51	523.05	776.44	778.2	612.32
Other Current Assets	86.67	51.08	53.5	98.56	135.05
Total Current Assets	1,367	1,094	1,110	1,369	1,043
Property, Plant & Equipment	261.14	261.66	263.49	229.46	208.04
Goodwill	0.84	0.84	0.84	0.84	0.84
Other Intangible Assets	46.96	51.69	57.07	63.33	63.25
Long-Term Accounts Receivable	-	43.37	14.51	-	-
Long-Term Deferred Tax Assets	59.94	36.74	3.06	-	0.91
Other Long-Term Assets	24.24	8.14	6.08	6.73	13.45
Total Assets	1,760	1,496	1,456	1,670	1,329
Accounts Payable	1,149	837.49	761.92	1,090	721.97
Accrued Expenses	7.97	13.81	13.22	9.98	13.25
Short-Term Debt	-	149.12	126.03	-	73.63
Current Portion of Long-Term Debt	195.06	16.67	-	-	12.89
Current Portion of Leases	2.61	2.53	2.03	0.29	7.29
Current Income Taxes Payable	-	-	-	1.16	-
Current Unearned Revenue	-	-	-	3.09	2.83
Other Current Liabilities	72.1	75.2	60.21	37.31	42.02
Total Current Liabilities	1,426	1,095	963.41	1,142	873.86
Long-Term Debt	1.92	18.19	0.13	0.13	20.79
Long-Term Leases	4.56	7.17	9.16	0.58	0.01
Long-Term Deferred Tax Liabilities	-	-	-	3.51	-
Other Long-Term Liabilities	28.5	3.86	3.56	2.32	11.66
Total Liabilities	1,461	1,146	993.63	1,165	921.16
Common Stock	97.83	95.83	95.83	95.83	95.83
Additional Paid-In Capital	-	134.64	134.64	134.64	134.64
Retained Earnings	-	118.42	231.09	273.53	176.83
Comprehensive Income & Other	200.99	1.32	1.29	0.91	0.76
Shareholders' Equity	298.82	350.2	462.84	504.9	408.05
Total Liabilities & Equity	1,760	1,496	1,456	1,670	1,329
Total Debt	204.14	193.67	137.36	0.99	114.61
Net Cash (Debt)	-156.48	-156.99	-120.49	80.05	-75.78
Net Cash Per Share	-16.31	-16.38	-12.57	8.35	-7.91
Filing Date Shares Outstanding	9.6	9.58	9.58	9.58	9.58
Total Common Shares Outstanding	9.6	9.58	9.58	9.58	9.58
Working Capital	-59.34	-1.01	146.84	227.59	168.81
Book Value Per Share	31.11	36.55	48.30	52.69	42.58
Tangible Book Value	251.02	297.66	404.93	440.73	343.96
Tangible Book Value Per Share	26.14	31.06	42.26	45.99	35.89
Land	-	0.47	0.47	0.47	0.47
Buildings	-	128.12	127.01	120.52	116.12
Machinery	-	220.37	210.78	172.22	125.26
Construction In Progress	-	12.87	10.42	10.16	18.72
Leasehold Improvements	-	6.03	6.03	6.03	6.03

Updated Jan 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.